Literature DB >> 1525603

Mixed chimerism in thalassemic patients after bone marrow transplantation.

S Nesci1, M Manna, M Andreani, P Fattorini, G Graziosi, G Lucarelli.   

Abstract

Seventy-four patients with homozygous beta-thalassemia who underwent allogeneic bone marrow transplantation (BMT) were analysed in order to evaluate the incidence and the significance of mixed chimerism (MC). Using a panel of four single locus specific minisatellite DNA probes, MC was found in 36.5%, 34.7% and 16.7% of the patients at 2, 6 and 12 months respectively after BMT. Moreover we found that different pretransplant conditioning regimens could be responsible for variations in the incidence of MC. The level of residual host cells found 2 months after BMT correlated with the occurrence of rejection.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1525603

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  7 in total

Review 1.  Survival of the fittest: in vivo selection and stem cell gene therapy.

Authors:  Tobias Neff; Brian C Beard; Hans-Peter Kiem
Journal:  Blood       Date:  2005-11-03       Impact factor: 22.113

Review 2.  Allogeneic hematopoietic stem cell transplantation for sickle cell disease: the time is now.

Authors:  Matthew M Hsieh; Courtney D Fitzhugh; John F Tisdale
Journal:  Blood       Date:  2011-05-31       Impact factor: 22.113

3.  High-level correction of the sickle mutation is amplified in vivo during erythroid differentiation.

Authors:  Wendy Magis; Mark A DeWitt; Stacia K Wyman; Jonathan T Vu; Seok-Jin Heo; Shirley J Shao; Finn Hennig; Zulema G Romero; Beatriz Campo-Fernandez; Suzanne Said; Matthew S McNeill; Garrett R Rettig; Yongming Sun; Yu Wang; Mark A Behlke; Donald B Kohn; Dario Boffelli; Mark C Walters; Jacob E Corn; David I K Martin
Journal:  iScience       Date:  2022-05-10

4.  Therapeutic effects of induced pluripotent stem cells in chimeric mice with β-thalassemia.

Authors:  Guanheng Yang; Wansheng Shi; Xingyin Hu; Jingzhi Zhang; Zhijuan Gong; Xinbing Guo; Zhaorui Ren; Fanyi Zeng
Journal:  Haematologica       Date:  2014-05-09       Impact factor: 9.941

5.  Relationship between mixed chimerism and rejection after bone marrow transplantation in thalassaemia.

Authors:  Marco Andreani; Manuela Testi; Mariarosa Battarra; Paola Indigeno; Annalisa Guagnano; Paola Polchi; Giorgio Federici; Guido Lucarelli
Journal:  Blood Transfus       Date:  2008-07       Impact factor: 3.443

6.  Quantitatively different red cell/nucleated cell chimerism in patients with long-term, persistent hematopoietic mixed chimerism after bone marrow transplantation for thalassemia major or sickle cell disease.

Authors:  Marco Andreani; Manuela Testi; Javid Gaziev; Rossella Condello; Andrea Bontadini; Pier Luigi Tazzari; Francesca Ricci; Lidia De Felice; Francesca Agostini; Daniela Fraboni; Giuliana Ferrari; Mariarosa Battarra; Maria Troiano; Pietro Sodani; Guido Lucarelli
Journal:  Haematologica       Date:  2010-10-07       Impact factor: 9.941

7.  Unmanipulated Stem Cell Boost for Mixed Chimerism in Transfusion Dependent Thalassemia.

Authors:  Akanksha Garg; Akshay Shivchhand; Sandip Shah; Kamlesh Shah; Kinnari Patel; Harsha Panchal; Apurva Patel; Sonia Parikh
Journal:  Indian J Hematol Blood Transfus       Date:  2020-09-03       Impact factor: 0.915

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.